Susana Mellor-Pita1, Pablo Tutor-Ureta1, Silvia Rosado1, Khusama Alkadi1, Fernando Granado2, Carlos Jimenez-Ortiz3, Raquel Castejon4. 1. Systemic Autoimmune Diseases Unit, Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, Joaquin Rodrigo 2, 28222, Majadahonda, Madrid, Spain. 2. Biochemistry Service, Hospital Universitario Puerta de Hierro Majadahonda, Joaquin Rodrigo 2, 28222, Majadahonda, Madrid, Spain. 3. Neurology Service, Hospital Universitario Puerta de Hierro Majadahonda, Joaquin Rodrigo 2, 28222, Majadahonda, Madrid, Spain. 4. Systemic Autoimmune Diseases Unit, Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, Joaquin Rodrigo 2, 28222, Majadahonda, Madrid, Spain. raquel.castejon@salud.madrid.org.
Abstract
OBJECTIVES: Low serum levels of 25-hydroxyvitamin D (25(OH)D) have been associated with a higher frequency of risk factors and cardiovascular disease. The aim of this study is to evaluate the association of 25(OH)D, cardiovascular risk factors, and subclinical atherosclerosis in systemic lupus erythematosus (SLE) patients. METHOD: Forty-seven female SLE patients were studied. Data collected included demographics, SLE activity, disease damage, cardiovascular risk factors, and markers of subclinical atherosclerosis. Patient treatments and vitamin D and calcium supplementation (VitD-Ca) were recorded. Vitamin D deficiency was defined as serum 25(OH)D < 50 nmol/l measured by ultra-high-performance liquid chromatography. Atherosclerosis was assessed by measuring the carotid-femoral pulse wave velocity (PWV) by Doppler velocimetry and intima-media thickness (IMT) by B-mode ultrasound scanning. RESULTS: 61.7% of patients were vitamin D deficient with a mean level of 31.91 ± 10.21 nmol/l. Serum vitamin D concentration was significantly higher in the 23 patients taking VitD-Ca supplements than that in patients not supplemented (p = 0.004). No significant association was found between 25(OH)D serum levels and cardiovascular risk factors, disease activity, or different treatments for SLE. A significant positive correlation was found between 25(OH)D levels, PWV (p = 0.02), and IMT (p = 0.01); moreover, patients taking VitD-Ca supplements presented an increased arterial stiffness. CONCLUSION: Patients with arterial stiffness showed higher levels of serum vitamin D and most of them were on VitD-Ca supplements. Although prospective studies with a larger number of patients and follow-up are needed, our findings suggest that VitD-Ca supplementation may have effects on SLE patients' arterial stiffness.
OBJECTIVES: Low serum levels of 25-hydroxyvitamin D (25(OH)D) have been associated with a higher frequency of risk factors and cardiovascular disease. The aim of this study is to evaluate the association of 25(OH)D, cardiovascular risk factors, and subclinical atherosclerosis in systemic lupus erythematosus (SLE) patients. METHOD: Forty-seven female SLEpatients were studied. Data collected included demographics, SLE activity, disease damage, cardiovascular risk factors, and markers of subclinical atherosclerosis. Patient treatments and vitamin D and calcium supplementation (VitD-Ca) were recorded. Vitamin D deficiency was defined as serum 25(OH)D < 50 nmol/l measured by ultra-high-performance liquid chromatography. Atherosclerosis was assessed by measuring the carotid-femoral pulse wave velocity (PWV) by Doppler velocimetry and intima-media thickness (IMT) by B-mode ultrasound scanning. RESULTS: 61.7% of patients were vitamin D deficient with a mean level of 31.91 ± 10.21 nmol/l. Serum vitamin D concentration was significantly higher in the 23 patients taking VitD-Ca supplements than that in patients not supplemented (p = 0.004). No significant association was found between 25(OH)D serum levels and cardiovascular risk factors, disease activity, or different treatments for SLE. A significant positive correlation was found between 25(OH)D levels, PWV (p = 0.02), and IMT (p = 0.01); moreover, patients taking VitD-Ca supplements presented an increased arterial stiffness. CONCLUSION:Patients with arterial stiffness showed higher levels of serum vitamin D and most of them were on VitD-Ca supplements. Although prospective studies with a larger number of patients and follow-up are needed, our findings suggest that VitD-Ca supplementation may have effects on SLEpatients' arterial stiffness.
Authors: Diane L Kamen; Glinda S Cooper; Henda Bouali; Stephanie R Shaftman; Bruce W Hollis; Gary S Gilkeson Journal: Autoimmun Rev Date: 2005-06-21 Impact factor: 9.754
Authors: S Manzi; E N Meilahn; J E Rairie; C G Conte; T A Medsger; L Jansen-McWilliams; R B D'Agostino; L H Kuller Journal: Am J Epidemiol Date: 1997-03-01 Impact factor: 4.897
Authors: H Amital; Z Szekanecz; G Szücs; K Dankó; E Nagy; T Csépány; E Kiss; J Rovensky; A Tuchynova; D Kozakova; A Doria; N Corocher; N Agmon-Levin; V Barak; H Orbach; G Zandman-Goddard; Y Shoenfeld Journal: Ann Rheum Dis Date: 2010-05-03 Impact factor: 19.103
Authors: Mario García-Carrasco; Claudia Mendoza-Pinto; Jorge Ayón-Aguilar; Pamela Soto-Santillán; Alma Rodríguez-Gallegos; Marco Antonio Escamilla-Márquez; Socorro Méndez-Martínez Journal: Gac Med Mex Date: 2016-10 Impact factor: 0.302
Authors: Apinya Lertratanakul; Peggy Wu; Alan Dyer; Murray Urowitz; Dafna Gladman; Paul Fortin; Sang-Cheol Bae; Caroline Gordon; Ann Clarke; Sasha Bernatsky; John G Hanly; David Isenberg; Anisur Rahman; Joan Merrill; Daniel J Wallace; Ellen Ginzler; Munther Khamashta; Ian Bruce; Ola Nived; Gunnar Sturfelt; Kristjan Steinsson; Susan Manzi; Mary Anne Dooley; Kenneth Kalunian; Michelle Petri; Cynthia Aranow; Josep Font; Ronald van Vollenhoven; Thomas Stoll; Rosalind Ramsey-Goldman Journal: Arthritis Care Res (Hoboken) Date: 2014-08 Impact factor: 4.794